Cargando…

Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT

PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [(18)F]-FDG PET/CT on a digital PET/CT were retrospectively evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Ian, Sachpekidis, Christos, Prenosil, George, Viscione, Marco, Bohn, Karl Peter, Mingels, Clemens, Shi, Kuangyu, Ashar-Oromieh, Ali, Rominger, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981298/
https://www.ncbi.nlm.nih.gov/pubmed/33550515
http://dx.doi.org/10.1007/s12149-021-01588-6
_version_ 1783667524245651456
author Alberts, Ian
Sachpekidis, Christos
Prenosil, George
Viscione, Marco
Bohn, Karl Peter
Mingels, Clemens
Shi, Kuangyu
Ashar-Oromieh, Ali
Rominger, Axel
author_facet Alberts, Ian
Sachpekidis, Christos
Prenosil, George
Viscione, Marco
Bohn, Karl Peter
Mingels, Clemens
Shi, Kuangyu
Ashar-Oromieh, Ali
Rominger, Axel
author_sort Alberts, Ian
collection PubMed
description PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [(18)F]-FDG PET/CT on a digital PET/CT were retrospectively evaluated. Scan data were anonymously obtained and reconstructed in list-mode acquisition for a standard 2 min/bed position (bp), 1 min/bp and 30 s/bp (100%, 50% and 25% time or applied activity, respectively). Scans were randomized and read by two nuclear medicine physicians in a consensus read. Readers were blind to clinical details. Scans were evaluated for the number of pathological lesions detected. Measured uptake for lesions was evaluated by maximum and mean standardized uptake value (SUVmax and SUVmean, respectively) and tumour-to-backround ratio (TBR) were compared. Agreement between the three acquisitions was compared by Krippendorf’s alpha. RESULTS: Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K’s α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). CONCLUSION: Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment.
format Online
Article
Text
id pubmed-7981298
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-79812982021-04-12 Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT Alberts, Ian Sachpekidis, Christos Prenosil, George Viscione, Marco Bohn, Karl Peter Mingels, Clemens Shi, Kuangyu Ashar-Oromieh, Ali Rominger, Axel Ann Nucl Med Original Article PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [(18)F]-FDG PET/CT on a digital PET/CT were retrospectively evaluated. Scan data were anonymously obtained and reconstructed in list-mode acquisition for a standard 2 min/bed position (bp), 1 min/bp and 30 s/bp (100%, 50% and 25% time or applied activity, respectively). Scans were randomized and read by two nuclear medicine physicians in a consensus read. Readers were blind to clinical details. Scans were evaluated for the number of pathological lesions detected. Measured uptake for lesions was evaluated by maximum and mean standardized uptake value (SUVmax and SUVmean, respectively) and tumour-to-backround ratio (TBR) were compared. Agreement between the three acquisitions was compared by Krippendorf’s alpha. RESULTS: Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K’s α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). CONCLUSION: Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment. Springer Singapore 2021-02-07 2021 /pmc/articles/PMC7981298/ /pubmed/33550515 http://dx.doi.org/10.1007/s12149-021-01588-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Alberts, Ian
Sachpekidis, Christos
Prenosil, George
Viscione, Marco
Bohn, Karl Peter
Mingels, Clemens
Shi, Kuangyu
Ashar-Oromieh, Ali
Rominger, Axel
Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title_full Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title_fullStr Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title_full_unstemmed Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title_short Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
title_sort digital pet/ct allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)f]-fdg pet/ct
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981298/
https://www.ncbi.nlm.nih.gov/pubmed/33550515
http://dx.doi.org/10.1007/s12149-021-01588-6
work_keys_str_mv AT albertsian digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT sachpekidischristos digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT prenosilgeorge digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT viscionemarco digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT bohnkarlpeter digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT mingelsclemens digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT shikuangyu digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT asharoromiehali digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct
AT romingeraxel digitalpetctallowsforshorteracquisitionprotocolsorreducedradiopharmaceuticaldosein18ffdgpetct